Kochi, Japan

Takahira Kuno

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Kochi University, Sbi Pharmaceuticals Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahira Kuno. Retrieved from https://idiyas.com/inventor/takahira-kuno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takahira Kuno: Innovator in Overactive Bladder Treatment

Introduction

Takahira Kuno is a notable inventor based in Kochi, Japan. He has made significant contributions to the field of medical therapeutics, particularly in the treatment of overactive bladder conditions. His innovative approach aims to address the limitations of existing therapeutic drugs.

Latest Patents

Kuno holds a patent for a prophylactic or therapeutic agent for overactive bladder. This invention is particularly important as it utilizes 5-aminolevulinic acids (ALAs) as the active ingredient. The need for effective treatments without the side effects commonly associated with existing medications has driven the development of this patent. His work is crucial in providing new options for patients suffering from this condition.

Career Highlights

Throughout his career, Takahira Kuno has worked with reputable organizations such as Sbi Pharmaceuticals Co., Ltd. and Kochi University. His experience in these institutions has allowed him to refine his research and contribute to advancements in medical science.

Collaborations

Kuno has collaborated with esteemed colleagues, including Tohru Tanaka and Kiwamu Takahashi. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Takahira Kuno's innovative contributions to the treatment of overactive bladder highlight his commitment to improving patient care. His patent for a therapeutic agent using ALAs represents a significant advancement in the field. Kuno's work continues to inspire future research and development in medical therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…